Background: Congenital hypothyroidism is a common congenital endocrine disorder prevailing all over the world. No nationwide screening exists for any sub-Saharan country. We present normative cord and capillary thyroid-stimulating hormone (TSH) values for healthy Nigerian newborns. Subjects and Methods: A cross-sectional study was carried out in 6 university hospitals in Nigeria between January 1 and December 31, 2013. Cord and heel blood placed on 4 concentric circles on a Whartman filter paper were analysed for TSH within 1 week of collection using AutoDelfia 1235 immunoassay (Perkin Elmer Wallace, Boston, Mass., USA) at Charité - Universitätsmedizin Berlin, Berlin, Germany. The mean TSH levels of the newborns were determined, considering their sex, birthweight, socioeconomic status, and birth city. The association between the mean TSH level and other parameters was determined by analysis of variance. Results: A total of 2,014 subjects were recruited during the study period. The mean TSH value for the subjects was 1.86 μIU/ml, and 98.1% of the newborns were within the 2.5th and 97.5th percentiles (range: 0.09-7.90 μIU/ml) of the TSH levels. We collected 247 cord and 1,767 heel samples, respectively, and the range was slightly higher in samples from cord blood. Conclusion: The study highlights the normal reference values for capillary/cord TSH levels in term Nigerian newborns. TSH was higher in one region, attributable to earlier sampling, but was not influenced by gender, socioeconomic status, or birthweight.

Keywords:
Congenital hypothyroidism, Thyroid-stimulating hormone , Newborns, Nigeria
1.
Gruters A, Biebermann H, Krude H: Neonatal thyroid disorders. Horm Res 2003;59(suppl 1):24-29.
2.
Fisher DA, Grueters A: Thyroid disorders in childhood and adolescence; in Sperling MA (ed): Pediatric Endocrinology, ed. 3. Philadelphia, Saunders-Elsevier, 2008, pp 227-253.
3.
Brown RS, Rose SR: Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117:2290-2303.
4.
Kaplowitz PB: Subclinical hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int J Pediatr Endocrinol 2010;2010:281453.
5.
Freire C, Ramos R, Amaya E, Fernández MF, Santiago-Fernández P, Lopez-Espinosa M, Arrebola J, Olea N: Newborn TSH concentration and its association with cognitive development in healthy boys. Eur J Endocrinol 2010;163:901-909.
6.
Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT; American Association of Clinical Endocrinologists; American Thyroid Association; Endocrine Society: Consensus statement No. 1: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Thyroid 2005;15:24-28; response 32-33.
7.
De Escobar GM, Obregó MJ, Escobar del Rey F: Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004;18:225-248.
8.
Santiago-Fernandez P, Torres-Barahona R, Muela-Martínez JA, Rojo-Martínez G, García-Fuentes E, Garriga MJ, León AG, Soriguer F: Intelligence quotient and iodine intake: a cross-sectional study in children. J Clin Endocrinol Metab 2004;89:3851-3857.
9.
Adesanmi TA, Adimora GN, Tagbo BN: Congenital hypothyroidism - a delayed diagnosis in a neonate. A case report. Niger J Clin Pract 2009;12:208-211.
10.
Idris HW, Mado SM, Abdullahi S, et al: Congenital hypothyroidism: a call for renewed efforts towards neonatal screening. Niger J Paediatr 2013;40:347-348.
11.
Laditan AA, Johnson AO: Thyroid gland disorders in African children. J Natl Med Assoc 1979;71:139-141.
12.
Jaja T, Yarhere IE: Clinical characteristics of children and adolescents with thyroid disorders seen at the University of Port Harcourt Teaching Hospital: a five-year review. Niger J Paediatr 2014;41:302-306.
13.
Ibekwe MU, Ibekwe RC, Okolo AA, Cheetham TD: Screening for hypothyroidism in schools for children with learning difficulties in Southeastern Nigeria. J Trop Pediatr 2013;59:330-331.
14.
Egbuta J, Onyezili F, Vanormelingen K: Impact evaluation of efforts to eliminate iodine deficiency disorders in Nigeria. Public Health Nutr 2003;6:169-173.
15.
Oyedeji GA: Socioeconomic and cultural background of hospitalised children in Ilesa. Niger J Paediatr 1985;12:111-117.
16.
Verburg FA, Kirchgassner C, Hebestreit H, Steigerwald U, Lentjes EG, Ergezinger K, Grelle I, Reiners C, Luster M: Reference ranges for analytes of thyroid function in children. Horm Metab Res 2011:43;422-426.
17.
Lem AJ, de Rijke YB, van Toor H, de Ridder MAJ, Visser TJ, Hokken-Koelega ACS: Serum thyroid hormone levels in healthy children from birth to adulthood and in short children born small for gestational age. J Clin Endocrinol Metab 2012;97:3170-3178.
18.
Medici M, de Rijke YB, Peeters RP, Visser W, de Muinck Keizer-Schrama SMPF, Jaddoe VVW, Hofman A, Hooijkaas H, Steegers EAP, Tiemeier H, Bongers-Schokking JJ, Visser TJ: Maternal early pregnancy and newborn thyroid hormone parameters: the Generation R Study. J Clin Endocrinol Metab 2012;97:646-652.
19.
Cockburn J, Redman S, Hill D, Henry E: Public understanding of medical screening. J Med Screen 1995;2:224-227.
20.
Das SC, Isichie UP, Otokwuala AA, Emokpae MA, Mohammed AZ: Neonatal chemical hypothyroidism in Nigeria. Ann Trop Paediatr 2004;24:237-240.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.